[1] |
SUN Lin, DA Meihong, DONG Zhengbang, WANG Fei.
Bullous systemic lupus erythematosus with blisters and bullae as the first symptom: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 416-418.
|
[2] |
CHEN Xueqin, SONG Zhiqiang.
Update of skin tissue-resident memory T cells and inflammatory skin diseases recurrence
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 292-296.
|
[3] |
WANG Jianwen, CHEN Xuechao, ZHOU Guizhi, CHEN Shengli, LU Xianmei, ZHANG Xueyan, ZHANG Fan, LIU Yongxia.
Clinical and histopathological characters of 28 cases of subungual melanoma
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 182-185.
|
[4] |
CHANG Jiayu, QI Miao, WANG Yimin, LI Yongxi, SHI Tongxin.
Bullous pemphigoid occurred in a patient with severe plaque psoriasis treated with secukinumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 199-201.
|
[5] |
ZHANG Wei, WEN Jie, ZHOU Xiangzhao.
Rowell syndrome: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 207-209.
|
[6] |
XU Yang, ZHAN Weisheng, ZHAO Juhua.
Efficacy and safety of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis: a meta-analysis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 89-94.
|
[7] |
ZHANG Ting, CAO Yu.
Nodular melanoma misdiagnosed as trichoblastoma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 118-121.
|
[8] |
CUI Yinling, ZHENG Chunzhi, YU Yongmei, LIU Hong.
Palmoplantar psoriasis resistant to secukinumab successfully treated with tofacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 134-136.
|
[9] |
DENG Yazhi, KANG Xiaojing, DING Yuan.
Update of correlation between psoriasis and malignant tumors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 139-144.
|
[10] |
ZHANG Yuting, ZHAO Huixia, MENG Xin, ZHAO Jiale, HE Xiaoyuan.
Changes of skin and intestinal microflora in psoriasis mice based on 16S rRNA sequencing
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 15-20.
|
[11] |
DU Baiyinzi, WANG Huiping, LUO Suju.
Efficacy and safety comparation of adalimumab and secukinumab in the treatment of nail psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 26-30.
|
[12] |
LEI Mingjun, DU Yinghua, TIAN Zan, BAI Fan.
Secukinumab in the treatment of plaque psoriasis complicated with uveitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 45-47.
|
[13] |
MAN Chunhua, WANG Xianzhen, WANG Xiangtong, LI Yangyang, WANG Qing.
Effect of abrocitinib in a patient with secukinumab-induced eczematous eruption: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 56-58.
|
[14] |
ZHANG Likun, YUE Wuheng, ZOU Zhengyun.
Update of chimeric antigen receptor T cell in malignant melanoma
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 59-65.
|
[15] |
ZHENG Chunzhi, ZHANG Weilin, GUO Xiao, YANG Baoqi, YANG Qing, LIU Hong.
Efficacy and safety of ixekizumab and adalimumab in the treatment of moderate to severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 633-638.
|